MEC Practice Academy 11.19
Blog|Articles|November 3, 2026

Why patients skip ordered blood tests — and how practices can close the gap

Author(s)Web Golinkin
Fact checked by: Todd Shryock

About 1 in 3 U.S. adults avoid or delay blood tests, leaving physicians without results that inform most clinical decisions. Here's how easier scheduling, less-invasive collection options and clearer results communication can help patients complete ordered testing.

A patient may defer a routine checkup because they anticipate a blood draw that makes them squeamish. Or after a provider orders blood work, they may intend to follow through but never complete the test. In either case, the sample is never drawn, results are never reported and an important clinical question may remain unanswered.

This is not uncommon. In Aflac’s 2026 survey of U.S. adults ages 18 to 65, roughly one in three reported avoiding or putting off a blood test. That gap matters. The CDC has stated that laboratory tests inform roughly 70% of medical decisions, meaning an order that goes uncompleted can leave an important part of the clinical picture unresolved. When clinically indicated testing is not completed, providers have less information to successfully diagnose, monitor or treat a condition, and necessary evaluation or follow-up may be delayed.

There can also be a practice-level consequence. Patients often experience diagnostic follow-through as part of the care they receive from the provider who placed the order — not as a separate laboratory transaction. If testing is inconvenient, stressful or confusing, that frustration can reflect on the provider’s organization, weakening trust and future engagement. In a 2022 online survey of more than 2,000 U.S. adults conducted by The Harris Poll on behalf of Tegria, 69% of respondents said they would consider changing providers for better services, underscoring that operational friction can become a retention issue, not merely an adherence issue.

Diagnostic follow-through can break down before or after a visit. Some patients postpone routine care because they are fearful or anxious about venipuncture. Others leave with an order and face the added burden of locating a lab, scheduling a separate appointment and frequently waiting in line. Needle anxiety and prior difficult experiences can make the collection experience itself an important — and often underestimated — barrier to completing ordered testing.

Closing that gap starts with a simple question: How easy is it for the patient to access, complete and understand the test? In practice, the answer comes down to convenience, collection experience and communication.

Convenience: Removing access barriers

One common barrier to completing testing is simply getting to the test site. Many organizations are expanding collection options beyond traditional patient-service centers, including ambulatory, retail and community settings. These models require strong operational foundations: laboratory information-system integration, standardized collection protocols, proper specimen preparation and handling, and chain-of-custody documentation.

Scheduling is another important variable. Rigid appointment windows and difficult-to-navigate scheduling interfaces can add friction. Practices have several tools to consider, including open-access scheduling, self-scheduling, mobile check-in and reminder outreach. A 2024 systematic review by Mazaheri Habibi et al. found that 10 of 16 studies reported significant reductions in outpatient no-show rates after open-access scheduling, although results varied by setting and implementation.

The lesson is straightforward: scheduling should fit into patients’ lives rather than force patients to organize their lives around a lab appointment. Otherwise, providers risk creating an experience patients remember as difficult and impersonal.

Collection: Minimizing invasiveness

Needle fear is another meaningful barrier. McLenon and Rogers' 2019 systematic review in the Journal of Advanced Nursing estimated needle fear at 20% to 50% among adolescents and 20% to 30% among young adults. Explaining the clinical rationale remains important, but information alone may not overcome fear or logistical barriers.

For selected tests performed through specifically validated workflows, capillary blood collection or micro-sampling can be an appropriate alternative to venous collection. But capillary and venous specimens are not interchangeable by default. Suitability depends on the analyte, collection device, specimen management, assay method, intended use and the performing laboratory’s validation.

Peer-reviewed research has demonstrated clinical equivalence to conventional testing across a broad range of routine tests. For other tests, conventional venipuncture remains the appropriate standard. In advanced, integrated microsample workflows, automated preparation may standardize key pre-analytic steps and reduce manual handling. Sample performance depends on the fully validated workflow, including assay selection, collection, preparation, transport and laboratory processes.

Providers do not need to become collection-technology experts. They do need to understand when a validated alternative may be available, when venipuncture remains necessary, and how to direct patients to assay-specific information about their options.

The goal is not to replace venipuncture in every circumstance. It is to give providers a clinically appropriate option when the test, workflow and patient preference or presentation support it, removing one more barrier to completing an order.

Results: Following through

Even a convenient collection experience may fall short if results are delayed, inaccessible or unclear. A systematic review of ambulatory care by Callen et al. found that failures to follow up on test results were common and linked to delayed or missed diagnoses. This makes post-collection communication a clinical concern.

Technology is an enabler, but the hard part is creating a follow-up process patients can understand and care teams can reliably execute. A single, accessible channel for test status and results can make the experience easier to navigate. Results should be reported in plain language and connected to a clear path for clinical interpretation. When an abnormal finding needs action, patients should know who will contact them, when that follow-up will occur, and what to do if they have questions.

Taking ownership

The diagnostics system has an alignment problem. Barriers may arise before an order is placed, when a patient avoids a visit because of anticipated discomfort or inconvenience, or afterward, when completing an order requires additional scheduling, travel, time away from work and a blood draw.

Providers cannot force blood testing adherence. But providers, health care organizations, laboratories and technology partners can improve it by sharing responsibility for making the end-to-end process easy to navigate, comfortable and productive.

With clinical decision-making so dependent on blood testing results, optimizing that process for patients makes sense from both care and practice management perspectives.

Web Golinkin is chief executive officer of Babson Diagnostics.


Related to this article